북미 임상실험실 서비스 시장 – 2031년까지의 산업 동향 및 예측

북미 임상실험실 서비스 시장 분석 및 규모

임상 검사 서비스 시장은 독립 및 참조 검사실, 병원 기반 검사실, 간호 및 의사 사무실 기반 검사실을 포함합니다. Quest Diagnostics와 같은 독립 검사실은 포괄적인 검사 서비스를 제공합니다. Mayo Clinic과 같은 병원 기반 검사실은 입원 환자 치료에 진단 지원을 제공합니다. LabCorp와 같은 간호 및 의사 사무실 기반 검사실은 다양한 의료 요구 사항을 충족하는 외래 환자 서비스를 위한 편리한 검사 시설을 제공합니다.

Data Bridge Market Research는 2023년에 1,27,237.23백만 달러였던 북미 임상 검사 서비스 시장이 2031년까지 2,23,569.21백만 달러에 도달할 것으로 분석했으며, 2024년부터 2031년까지 예측 기간 동안 7.3%의 CAGR을 기록할 것으로 예상합니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

북미 임상실험실 서비스 시장 범위 및 세분화  

시장 정의

임상 검사 서비스는 건강 상태나 질병 존재를 평가하기 위해 환자 검체에서 수행되는 진단 절차를 말합니다. 이러한 서비스에는 혈액 분석, 미생물 배양, 유전자 검사를 포함한 광범위한 검사가 포함되어 있어 의료 환경에서 의학적 의사 결정과 환자 치료에 중요한 정보를 제공합니다.

북미 임상실험실 서비스 시장 역학

운전자

• 기술 혁신으로 효율성과 정확성이 향상됩니다.

기술 혁신은 진단 검사 절차의 효율성과 정확성을 지속적으로 향상시켜 환자 결과를 개선하고 의료 프로세스를 간소화합니다. 자동화된 검사 시스템에서 고급 분석 장비에 이르기까지 이러한 혁신을 통해 실험실은 더 많은 양의 검사를 더 정밀하게 처리할 수 있으며, 빠르게 진화하는 의료 환경에서 진단 서비스에 대한 수요 증가에 부응할 수 있습니다.

• 고령화 사회로 인해 더 많은 진단 검사가 필요함

노화되는 개인은 심혈관 질환, 당뇨병, 암과 같은 연령 관련 건강 상태를 모니터링하고 관리하기 위해 진단 검사가 증가해야 합니다. 이러한 인구 통계적 변화는 의료 서비스 제공자가 예방 관리와 조기 질병 탐지를 강조함에 따라 실험실 서비스에 대한 수요를 촉진합니다. 결과적으로 임상 실험실 서비스 시장은 노령 인구의 진화하는 의료 요구를 해결해야 하는 필수성에 의해 지속적인 성장을 경험합니다.

기회

• 임상 시험을 위한 제약 회사와의 협력

협력을 통해 실험실은 약물 개발, 효능 및 안전성 평가에 필요한 전문 테스트 서비스를 제공할 수 있습니다. 이 파트너십을 통해 실험실은 고객을 확대하고 최첨단 연구에 액세스하며 제약 산업의 핵심 참여자로 자리 매김할 수 있습니다. 또한 혁신을 촉진하고 의료 분야의 발전에 기여하여 궁극적으로 시장에서 성장과 수익성을 촉진합니다.

• 농촌 지역으로의 테스트 서비스 확장

Reaching underserved communities enables laboratories to fulfill unmet healthcare needs, enhancing overall patient care and access to diagnostic testing. This expansion opens new markets, boosts revenue streams, and bolsters the laboratory's reputation for serving diverse populations. Moreover, it aligns with healthcare equity goals, displaying social responsibility and nurturing long-term sustainability and growth within the market.

Restraints/Challenges

• Regulatory Compliance Complexities Hinder Operational Efficiency

Stricter regulations increase administrative burdens, leading to longer processing times and higher operational costs. This can result in delays in test reporting, reduced throughput capacity, and overall inefficiencies in laboratory operations. Ultimately, these challenges may limit the ability of laboratory providers to meet the growing demand for diagnostic services, potentially impacting market growth and profitability.

• Data Security and Privacy Concerns Impede Digitalization Efforts

Heightened scrutiny over the protection of sensitive patient information slows down the adoption of digital technologies and cloud-based solutions. This impediment delays the implementation of streamlined processes, inhibiting efficiency gains and limiting scalability. Additionally, reluctance to digitize may hinder collaboration and data sharing among healthcare providers, impacting the delivery of integrated care and potentially hinder market advancement.

This North America clinical laboratory services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the North America clinical laboratory services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2023, DiaCarta, Ltd. collaborated with Hopkins MedTech Lab Services and Hopkins MedTech Compliance to aid in the development and validation of laboratory-developed tests (LDTs) in the United States. This partnership aimed to bolster DiaCarta's presence in the clinical laboratory services market, facilitating the advancement and regulatory compliance of their testing capabilities
• In 2023, Laboratory Corporation of America Holdings (Labcorp) entered an agreement with Tufts Medicine to acquire its Outreach Laboratory Business. This strategic move aimed to expand Labcorp's diagnostic testing and laboratory services offerings, further solidifying its position in the healthcare industry and enhancing its ability to meet the evolving needs of patients and healthcare providers
• In February 2023, Detact Diagnostics, a Dutch biotech company, established a new laboratory at Keene State College (U.S.) under a 2-year rental contract. This expansion aimed to strengthen Detact Diagnostics' presence in the clinical laboratory services market, enabling enhanced research and development capabilities for diagnostic technologies and services
• In 2021, Mayo Clinic Laboratories became a United Healthcare Preferred Lab Network (PLN) care provider, offering in-network access to comprehensive subspecialty testing for United Healthcare members. This accreditation bolstered the company's popularity in subspecialty testing within the clinical laboratory services market, expanding its reach and reputation among healthcare providers and patients alike

North America Clinical Laboratory Services Market Scope

The North America clinical laboratory services market is segmented on the basis of service type, speciality, provider and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Service Type

• Routine Testing Services
• Esoteric Services
• Anatomic Pathology Services

Speciality

• Clinical Chemistry Testing
• Hematology Testing
• Microbiology Testing
• Immunology Testing
• Drugs of Abuse Testing
• Cytology Testing
• Genetic Testing

 Provider

• Hospital-Based Laboratories
• Independent and Reference Laboratories
• Nursing and Physician Office-Based Laboratories

 Application

• Bioanalytical and Lab Chemistry Services
• Drug Development Related Services
• Drug Discovery Related Services
• Toxicology Testing Services
• Cell and Gene Therapy Related Services
• Preclinical and Clinical Trial Related Services
• Other Clinical Laboratory Services

North America Clinical Laboratory Services Market Regional Analysis/Insights

The North America clinical laboratory services market is analysed and market size insights and trends are provided by service type, speciality, provider and application as referenced above.

The countries covered in the North America clinical laboratory services market report are U.S., Canada and Mexico in North America.

The U.S. leads the clinical laboratory services market, propelled by escalating demand for timely and precise disease detection. The nation's advanced healthcare infrastructure, technological innovations, and emphasis on preventive medicine contribute to its dominance. This leadership position is further bolstered by a growing focus on early intervention and comprehensive healthcare delivery systems.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The North America clinical laboratory services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America clinical laboratory services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America clinical laboratory services market. The data is available for historic period 2016-2021.

Competitive Landscape and North America Clinical Laboratory Services Market Share Analysis

The North America clinical laboratory services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to North America clinical laboratory services market.

Some of the major players operating in the North America clinical laboratory services market are:

• BD (U.S.)
• Genomic Health (U.S.)
• Abbott (U.S.)
• Charles River (U.S.)
• H.U. Group Holdings, Inc. (China)
• Eurofins Scientific (Luxembourg)
• Laboratory Corporation of America Holding (U.S.)
• Mayo Foundation for Medical Education and Research (U.S.)
• DaVita Inc. (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Siemens Healthcare GmbH (Germany)
• ARUP Laboratories (U.S.)
• Lifelabs (Canada)
• BioReference Laboratories, Inc. (U.S.)
• NeoGenomics Laboratories, Inc. (U.S.)
• ACM Global Laboratories (U.S.)
• Sartorius AG (Germany)

SKU-50623